Department of Endocrinology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, China.
Front Endocrinol (Lausanne). 2021 Nov 5;12:766419. doi: 10.3389/fendo.2021.766419. eCollection 2021.
Previous studies on the association between thyroid function and non-alcoholic fatty liver disease (NAFLD) have contradicted. Acquired resistance to thyroid hormone theory might provide a reasonable explanation for these contradictions. We aimed to analyze the association between sensitivity to thyroid hormone indices with NAFLD.
A total of 4,610 individuals from the health medical center of the First Hospital of China Medical University were included in this study. The previously used thyroid feedback quantile-based index (TFQI) was calculated. Also, we substituted free triiodothyronine (FT) into the TFQI formulas to get the TFQI index. NAFLD was defined using abdominal ultrasound.
Study results showed that FT/FT and TFQI were positively correlated with the triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels (<0.05) and negatively correlated with high-density lipoprotein cholesterol (HDL-C) level (<0.05). In contrast, TFQI was positively correlated with HDL-C level ( < 0.05). After adjustment for multiple confounders, FT, FT/FT, and TFQI were positively associated with the risks of dyslipidemia and NAFLD ( < 0.05). TFQI and FT/FT performed better than TFQI on ROC analyses for NAFLD prediction, although the diagnostic sensitivity and specificity at the optimal cut-points were low. However, no association was observed between TFQI with the risks of dyslipidemia and NAFLD.
TFQI and FT/FT can be used as new indicators for predicting dyslipidemia and NAFLD, although with low sensitivity and specificity at the optimal cut-points, while TFQI has insufficient evidence in predicting dyslipidemia and NAFLD.
先前关于甲状腺功能与非酒精性脂肪性肝病(NAFLD)之间关联的研究结果相互矛盾。甲状腺激素抵抗理论可能为这些矛盾提供了合理的解释。我们旨在分析甲状腺激素敏感性指标与 NAFLD 之间的关联。
本研究共纳入了 4610 名来自中国医科大学第一医院健康医学中心的个体。计算了先前使用的甲状腺反馈定量指数(TFQI)。此外,我们将游离三碘甲状腺原氨酸(FT)代入 TFQI 公式中,得到 TFQI 指数。使用腹部超声定义 NAFLD。
研究结果表明,FT/FT 和 TFQI 与甘油三酯(TG)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平呈正相关(<0.05),与高密度脂蛋白胆固醇(HDL-C)水平呈负相关(<0.05)。相反,TFQI 与 HDL-C 水平呈正相关(<0.05)。在调整了多个混杂因素后,FT、FT/FT 和 TFQI 与血脂异常和 NAFLD 的风险呈正相关(<0.05)。ROC 分析显示,TFQI 和 FT/FT 对 NAFLD 的预测效果优于 TFQI,但最佳截断点的诊断敏感性和特异性较低。然而,TFQI 与血脂异常和 NAFLD 的风险之间没有关联。
TFQI 和 FT/FT 可作为预测血脂异常和 NAFLD 的新指标,尽管在最佳截断点的诊断敏感性和特异性较低,而 TFQI 预测血脂异常和 NAFLD 的证据不足。